Compass Oncology Rose Quarter — Portland, Oregon

Compass Oncology Rose Quarter is a clinical research site located in Portland, Oregon, United States 97227.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

Compass Oncology Rose Quarter has participated in 24 clinical trials with 10 currently active.

Therapeutic areas: High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma.

Sponsors: Genmab, National Cancer Institute (NCI), NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

• Oregon Health and Science University, CHH1
• Oregon Health & Science University (OHSU), Site 048
• Oregon Health & Science University OHS University
• Oregon Health and Science University, Doernbecher Children's Hospital
• Oregon Health Sciences University Hospital
• Oregon Health & Science University OHSU Knight Cancer Institute
• Oregon Health and Science University /ID# 149774
• Legacy Emanuel Research Hospital Portland
• Oregon Health and Science University /ID# 221801
• Oregon Health Sciences University SC-6
• Oregon Health and Science University Dept. Hematologic Malignancies
• VA Portland Health Care Services

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology Rose Quarter?

Compass Oncology Rose Quarter has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology Rose Quarter conducted?

Compass Oncology Rose Quarter has 24 clinical trials on record, with 10 currently active. Their work covers High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma.

Is Compass Oncology Rose Quarter accredited by Crixeo Clinical Trials?

Compass Oncology Rose Quarter has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Compass Oncology Rose Quarter?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.